Sequential outbreaks in a Spanish hospital caused by multiresistant OXA-58-producing Acinetobacter baumannii ST92

Journal of Medical Microbiology

Volumn 63, Issue PART 8, 2014, Pages 1093-1098

  Cabrera Alvargonzalez, Jorge Julio ^a   Hernando, Ana Vindel ^b   Martín, Maria Dolores Rojo ^a   Casas, Consuelo Miranda ^a   Iglesias, Jesús Oteo ^b   Marín, Mari Fe Bautista ^a   Alvarez, Maria Luisa Azañedo ^b   Sanchez, Veronica Bautista ^b   Marí, Jose Maria Navarro ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; SPAIN; TIME FACTORS;

EID: 84905172309     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.067280-0     Document Type: Article

References (20)

1. Adams-Haduch, J. M., Onuoha, E. O., Bogdanovich, T., Tian, G. B., Marschall, J., Urban, C. M., Spellberg, B. J., Rhee, D., Halstead, D. C. & other authors (2011). Molecular epidemiology of carbapenemnonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol 49, 3849-3854.
2. Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A., Wisplinghoff, H. & Rodríguez-Valera, F. (2005). Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43, 4382-4390.
3. CLSI (2011). Performance Standards for Antimicrobial Susceptibility Testing; 21st Informational Supplement M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute.
4. Endo, S., Yano, H., Hirakata, Y., Arai, K., Kanamori, H., Ogawa, M., Shimojima, M., Ishibashi, N., Aoyagi, T. & other authors (2012). Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan. J Antimicrob Chemother 67, 1623-1626.
5. Fernández-Cuenca, F., Pascual, A., Ribera, A., Vila, J., Bou, G., Cisneros, J. M., Rodríguez-Bañ o, J., Pachón, J., Martínez-Martínez, L. & Grupo de Estudio de Infección Hospitalaria (2004). Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000). Enferm Infecc Microbiol Clin 22, 267-271 (in Spanish).
6. Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C. & Hughes, J. M. (1988). CDC definitions for nosocomial infections, 1988. Am J Infect Control 16, 128-140.
7. Jawad, A., Hawkey, P. M., Heritage, J. & Snelling, A. M. (1994). Description of Leeds Acinetobacter Medium, a new selective and differential medium for isolation of clinically important Acinetobacter spp., and comparison with Herellea agar and Holton's agar. J Clin Microbiol 32, 2353-2358.
8. Lopes, B. S., Evans, B. A. & Amyes, S. G. (2012). Disruption of the blaOXA-51-like gene by ISAba16 and activation of the blaOXA-58 gene leading to carbapenem resistance in Acinetobacter baumannii Ab244. J Antimicrob Chemother 67, 59-63.
9. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G. & other authors (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18, 268-281.
10. Marqué, S., Poirel, L., Héritier, C., Brisse, S., Blasco, M. D., Filip, R., Coman, G., Naas, T. & Nordmann, P. (2005). Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol 43, 4885-4888.
11. Mugnier, P. D., Poirel, L., Naas, T. & Nordmann, P. (2010). Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 16, 35-40.
12. Nigro, S. J. & Hall, R. M. (2012). Tn6167, an antibiotic resistance island in an Australian carbapenem-resistant Acinetobacter baumannii GC2, ST92 isolate. J Antimicrob Chemother 67, 1342-1346.
13. Ruiz, M., Marti, S., Fernandez-Cuenca, F., Pascual, A. & Vila, J. (2007). High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect 13, 1192-1198.
14. Rumbo, C., Gato, E., López, M., Ruiz de Alegría, C., Fernández- Cuenca, F., Martínez-Martínez, L., Vila, J., Pachón, J., Cisneros, J. M. & other authors (2013). Contribution of efflux pumps, porins, and blactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 57, 5247-5257.
15. Seifert, H., Dolzani, L., Bressan, R., van der Reijden, T., van Strijen, B., Stefanik, D., Heersma, H. & Dijkshoorn, L. (2005). Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis- generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 43, 4328-4335.
16. Sevillano, E., Fernández, E., Bustamante, Z., Zabalaga, S., Rosales, I., Umaran, A. & Gallego, L. (2012). Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia. J Med Microbiol 61, 80-84.
17. Tacconelli, E., Cataldo, M. A., Dancer, S. J., De Angelis, G., Falcone, M., Frank, U., Kahlmeter, G., Pan, A., Petrosillo, N. & other authors (2014). ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 20 (Suppl 1), 1-55.
18. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233-2239.
19. Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M. & Pitt, T. L. (2006). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258, 72-77.
20. Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., Amyes, S. G. & Livermore, D. M. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27, 351-353.